rs6446384
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_147127.5(EVC2):c.1146-1813A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.686 in 152,052 control chromosomes in the GnomAD database, including 36,365 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.69 ( 36365 hom., cov: 32)
Consequence
EVC2
NM_147127.5 intron
NM_147127.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.84
Publications
3 publications found
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
- acrofacial dysostosis, Weyers typeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Ellis-van Creveld syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.813 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EVC2 | ENST00000344408.10 | c.1146-1813A>T | intron_variant | Intron 9 of 21 | 1 | NM_147127.5 | ENSP00000342144.5 | |||
| EVC2 | ENST00000310917.6 | c.906-1813A>T | intron_variant | Intron 9 of 21 | 1 | ENSP00000311683.2 | ||||
| EVC2 | ENST00000475313.5 | n.906-1813A>T | intron_variant | Intron 9 of 22 | 1 | ENSP00000431981.1 | ||||
| EVC2 | ENST00000509670.1 | n.906-1813A>T | intron_variant | Intron 10 of 22 | 1 | ENSP00000423876.1 |
Frequencies
GnomAD3 genomes AF: 0.685 AC: 104149AN: 151934Hom.: 36326 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
104149
AN:
151934
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.686 AC: 104237AN: 152052Hom.: 36365 Cov.: 32 AF XY: 0.682 AC XY: 50695AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
104237
AN:
152052
Hom.:
Cov.:
32
AF XY:
AC XY:
50695
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
34044
AN:
41488
American (AMR)
AF:
AC:
9526
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
2316
AN:
3466
East Asian (EAS)
AF:
AC:
3094
AN:
5148
South Asian (SAS)
AF:
AC:
2681
AN:
4804
European-Finnish (FIN)
AF:
AC:
6856
AN:
10558
Middle Eastern (MID)
AF:
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43624
AN:
67990
Other (OTH)
AF:
AC:
1429
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1623
3246
4868
6491
8114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2063
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.